• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名与16p11.2缺失相关的良性家族性婴儿癫痫患者身上生成人诱导多能干细胞系CIPi001-A。

Generation of a human iPSC line CIPi001-A from a benign familial infantile epilepsy patient related 16p11.2 deletion.

作者信息

Ji Xinna, Gao Yanyan, Zhang Pingping, Jin Ziqi, Zhang Yan, Yang Minna, Zhang Xue, Chen Qian

机构信息

Department of Neurology, Capital Institute of Pediatrics, China.

Harbin Medical University, China.

出版信息

Stem Cell Res. 2022 Mar;59:102634. doi: 10.1016/j.scr.2021.102634. Epub 2022 Jan 3.

DOI:10.1016/j.scr.2021.102634
PMID:34995844
Abstract

The features of 16p11.2 deletion phenotype is developmental delay, intellectual disability, and autism spectrum disorder. Seizures are observed in approximately 20% of individuals with the microdeletion. Induced pluripotent stem cells (iPSCs) were generated from erythroblasts obtained from a child diagnosed with benign familial infantile epilepsy, caused by 16p11.2 deletion. These iPSCs exhibited stable amplification, expressed pluripotent markers, and differentiated spontaneously into three germ layers in vitro.

摘要

16p11.2缺失表型的特征为发育迟缓、智力残疾和自闭症谱系障碍。在约20%的微缺失个体中观察到癫痫发作。诱导多能干细胞(iPSC)由一名被诊断患有由16p11.2缺失引起的良性家族性婴儿癫痫的儿童的成红细胞生成。这些iPSC表现出稳定扩增,表达多能性标志物,并在体外自发分化为三个胚层。

相似文献

1
Generation of a human iPSC line CIPi001-A from a benign familial infantile epilepsy patient related 16p11.2 deletion.从一名与16p11.2缺失相关的良性家族性婴儿癫痫患者身上生成人诱导多能干细胞系CIPi001-A。
Stem Cell Res. 2022 Mar;59:102634. doi: 10.1016/j.scr.2021.102634. Epub 2022 Jan 3.
2
The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population.临床确诊人群中16p11.2缺失的认知和行为表型。
Biol Psychiatry. 2015 May 1;77(9):785-93. doi: 10.1016/j.biopsych.2014.04.021. Epub 2014 Jun 16.
3
A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome.新病例报告:PRRT2 相关阵发性运动障碍伴 c.649dup 变异与 16p11.2 微缺失综合征同时存在。
Brain Dev. 2022 Aug;44(7):474-479. doi: 10.1016/j.braindev.2022.03.008. Epub 2022 Apr 7.
4
Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.与全面性发育迟缓、行为问题、畸形、癫痫和头围异常相关的反复性 16p11.2 重排。
J Med Genet. 2010 May;47(5):332-41. doi: 10.1136/jmg.2009.073015. Epub 2009 Nov 12.
5
Benign infantile seizures followed by autistic regression in a boy with 16p11.2 deletion.一名患有16p11.2缺失的男孩出现良性婴儿惊厥,随后出现自闭症退行。
Epileptic Disord. 2017 Jun 1;19(2):222-225. doi: 10.1684/epd.2017.0909.
6
Clinical Characteristics of Seizures and Epilepsy in Individuals With Recurrent Deletions and Duplications in the 16p11.2 Region.16p11.2区域存在重复和缺失的个体的癫痫发作及癫痫的临床特征
Neurol Genet. 2022 Aug 5;8(5):e200018. doi: 10.1212/NXG.0000000000200018. eCollection 2022 Oct.
7
[16p11.2 Microdeletion: first report in Argentina].[16p11.2微缺失:阿根廷首例报告]
Arch Argent Pediatr. 2017 Dec 1;115(6):e449-e453. doi: 10.5546/aap.2017.e449.
8
16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort.16p11.2缺失与重复:在一个大型临床确诊队列中对神经学表型进行特征描述
Am J Med Genet A. 2016 Nov;170(11):2943-2955. doi: 10.1002/ajmg.a.37820. Epub 2016 Jul 13.
9
[Clinical phenotype and genetic features of 16p11.2 microdeletion-related epilepsy in children].儿童16p11.2微缺失相关癫痫的临床表型及遗传学特征
Zhongguo Dang Dai Er Ke Za Zhi. 2022 May 15;24(5):585-590. doi: 10.7499/j.issn.1008-8830.2111110.
10
Benign infantile convulsions (IC) and subsequent paroxysmal kinesigenic dyskinesia (PKD) in a patient with 16p11.2 microdeletion syndrome.一名患有16p11.2微缺失综合征的患者出现良性婴儿惊厥(IC)及随后的发作性运动诱发性运动障碍(PKD)。
Neurogenetics. 2013 Nov;14(3-4):251-3. doi: 10.1007/s10048-013-0376-7. Epub 2013 Oct 8.

引用本文的文献

1
Regeneration of T cells from human-induced pluripotent stem cells for CAR-T cell medicated immunotherapy.从人诱导多能干细胞再生T细胞用于CAR-T细胞介导的免疫治疗。
Front Bioeng Biotechnol. 2023 May 18;11:1159507. doi: 10.3389/fbioe.2023.1159507. eCollection 2023.